US20070275893A1 - Compositions for enhanced epithelial permeation of peptide yy for treating obesity - Google Patents

Compositions for enhanced epithelial permeation of peptide yy for treating obesity Download PDF

Info

Publication number
US20070275893A1
US20070275893A1 US11/561,331 US56133106A US2007275893A1 US 20070275893 A1 US20070275893 A1 US 20070275893A1 US 56133106 A US56133106 A US 56133106A US 2007275893 A1 US2007275893 A1 US 2007275893A1
Authority
US
United States
Prior art keywords
seq id
delivery
peptide
peptide yy
mucosal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/561,331
Inventor
Steven Quay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marina Biotech Inc
Original Assignee
Marina Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/322,266 priority Critical patent/US7166575B2/en
Application filed by Marina Biotech Inc filed Critical Marina Biotech Inc
Priority to US11/561,331 priority patent/US20070275893A1/en
Publication of US20070275893A1 publication Critical patent/US20070275893A1/en
Assigned to MARINA BIOTECH, INC. (F/K/A MDRNA, INC.) reassignment MARINA BIOTECH, INC. (F/K/A MDRNA, INC.) RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CEQUENT PHARMACEUTICALS, INC.
Application status is Abandoned legal-status Critical

Links